Esophageal cancer, stomach, and esophagogastric junction cancers, Colorectal cancer, Hepatocellular carcinoma, Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Consent of the patient participating in the study has been confirmed through one of the following forms: 1. Written consent specific to this study has been obtained for participation in this study 2. Consent for SCRUM-Japan related study*1 has been obtained, and consent for secondary use, including commercial use, has not been revoked 2) Diagnostic confirmation as one of the following cancer types: 1. Esophageal cancer, stomach, and esophagogastric junction cancers 2. Colorectal cancer 3. Hepatocellular carcinoma 4. Pancreatic cancer
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival, Progression free surviva, Time to treatment failure, Frequency of various types of adverse events experienced during treatment | — |
Countries
Japan
Contacts
National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal Oncology